| Literature DB >> 32029876 |
Kui Li1,2, Zicheng Jiang2, Yanan Zhu3, Chuanqi Fan2, Tao Li2, Wenqi Ma4, Yingli He5.
Abstract
The objective of the present investigation was to explore the influencing factors and value of computed tomography (CT) for diagnosing severe chest lesions in active pulmonary tuberculosis (APTB). This retrospective investigation included 463 patients diagnosed with APTB. Relevant clinical features were collected. Patients were assigned to mild/moderate group or advanced group depending on the lesion severity on chest CT, severe chest CT lesion refers to the moderately dense or less diffuse lesion that exceeds the total volume of one lung, or the dense fusion lesion greater than one third of the volume of one lung, or the lesion with cavity diameter ≥4 cm. Independent risk factors for severe lesions were determined by univariate and multivariate logistic regression analyses, and the diagnostic efficiency of the risk factors was assessed by receiver operating characteristic curve (ROC). Chest CT demonstrated that there were 285 (61.56%) cases with severe lesions; multivariate Logistic regression analysis showed dust exposure [odds ratio (OR) = 4.108, 95% confidence interval (CI) 2.416-6.986], patient classification (OR = 1.792, 95% CI 1.067-3.012), age (OR = 1.018, 95% CI 1.005-1.030), and albumin-globulin ratio (OR = 0.179, 95% CI 0.084-0.383) to be independently correlated with severe lesions on chest CT. ROC curve analysis showed the cutoff values of age, albumin-globulin ratio and combined score to be 39 years, 0.918 and -0.085, respectively. The predictive value of combined score area under the curve 0.753 (95% CI 0.708-0.798) was higher than that of any single factor. The combined score of these four factors further improved the predictive efficacy.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32029876 PMCID: PMC7005193 DOI: 10.1038/s41598-020-59041-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Main characteristics of the severe lesions examined by chest CT examination.
| CT findings | Number ( |
|---|---|
| Patch-like shadow | 14 (4.91) |
| Filamentous shadow | 33 (11.58) |
| Cavity | 206 (72.28) |
| Thick-walled cavity | 116 (56.31) |
| Mouth-eaten cavity | 51 (24.76) |
| Thin-walled cavity | 9 (4.37) |
| Mixed cavity | 30 (14.56) |
| Speckled nodular shadow | 17 (5.96) |
| Cheese-like lesion | 12 (4.21) |
| Other lesionsa | 3 (1.06) |
CT: Computed tomography. aRefer to the patients with almost no lesion in the lung, mainly pleural effusion, and mycobacterium tuberculosis deoxyribonucleic acid or ribonucleic acid positive pleural effusion.
Univariate analysis of chest CT lesion degree (nominal and ordinal variables).
| Variable | Stage 1, 2 APTB (n = 178) | Stage 3 APTB (n = 285) | |||
|---|---|---|---|---|---|
| Sex, n (%) | Female | 45 (25.28) | 55 (19.30) | 2.316 | 0.128 |
| Male | 133 (74.72) | 230 (80.70) | |||
| Smoking history, n (%) | No | 90 (50.56) | 95 (33.33) | 13.556 | <0.001* |
| Yes | 88 (49.44) | 190 (66.67) | |||
| Dust exposure history, n (%) | No | 156 (87.64) | 174 (61.05) | 37.831 | <0.001* |
| Yes | 22 (12.36) | 111 (38.95) | |||
| Classification of cases, n (%) | Initial treatmenta | 145 (81.46) | 177 (62.11) | 19.381 | <0.001* |
| Retreatmentb | 33 (18.54) | 108 (37.89) | |||
| Extrapulmonary tuberculosis, n (%) | No | 154 (86.52) | 235 (82.46) | 1.345 | 0.246 |
| Yes | 24 (13.48) | 50 (17.54) | |||
| Diabetes mellitus, n (%) | No | 157 (88.20) | 263 (92.28) | 2.163 | 0.141 |
| Yes | 21 (11.80) | 22 (7.72) | |||
| Drug-resistant tuberculosis, n (%) | No | 163 (91.57) | 249 (87.37) | 1.976 | 0.160 |
| Yes | 15 (8.43) | 36 (12.63) | |||
| Gradec, n (%) | DNA/RNA positived | 42 (23.60) | 62 (21.75) | 3.065 | 0.690 |
| NC | 13 (7.30) | 14 (4.91) | |||
| 1+ | 50 (28.09) | 75 (26.32) | |||
| 2+ | 24 (13.48) | 47 (16.49) | |||
| 3+ | 34 (19.10) | 54 (18.95) | |||
| 4+ | 15 (8.43) | 33 (11.58) | |||
APTB: active pulmonary tuberculosis; CT: computed tomography; NC: The number of colony. aNew cases are defined as not starting anti-TB treatment or being on anti-TB treatment for <1 month; bPreviously treated cases are defined as those anti-TB treated ≥1 month in the past; cSmear grading before treatment; dMycobacterium tuberculosis deoxyribonucleic acid or ribonucleic acid positive; *Significant influence.
Univariate analysis of chest CT lesion degree (numeric variables).
| Variable | Stage 1, 2 APTB (n = 178) | Stage 3 APTB (n = 285) | Test value | |||
|---|---|---|---|---|---|---|
| Missing data n (%) | Median (interquartile range)a | Missing data n (%) | Median (interquartile range)a | |||
| Age (years) | 0 | 45.00 (26.75–60.00) | 0 | 53.00 (42.00–64.50) | 31795.50 | <0.001* |
| Body mass index (kg/m2) | 3 (1.69) | 19.267 (17.928–21.223) | 2 (0.70) | 19.111 (17.313–20.957) | 22619.00 | 0.119 |
| Duration of symptoms (days) | 0 | 60.00 (15.00–183.00) | 0 | 183.00 (30.00–1095.00) | 33495.50 | <0.001* |
| White blood cell (×109/L) | 0 | 6.29 (5.15–7.95) | 0 | 7.19 (5.57–8.98) | 29818.00 | 0.001* |
| Hematocrit (%) | 0 | 38.00 ± 6.21 | 0 | 36.42 ± 6.16 | 2.682 | 0.008* |
| Platelet (×109/L) | 0 | 247.00 (194.00–315.25) | 0 | 279.00 (208.50–346.50) | 28635.00 | 0.020* |
| ESR (mm/H) | 15 (8.43) | 40.00 (21.00–68.00) | 32 (11.23) | 58.00 (33.00–78.00) | 25879.50 | <0.001* |
| Albumin (g/L) | 0 | 32.49 ± 5.61 | 0 | 29.58 ± 6.07 | 5.176 | <0.001* |
| Globulin (g/L) | 3 (1.69) | 31.34 (27.81–35.07) | 2 (0.70) | 32.93 (29.50–36.96) | 29100.50 | 0.002* |
| Albumin-globulin ratio | 3 (1.69) | 1.036 (0.859–1.288) | 2 (0.70) | 0.879 (0.719–1.083) | 17218.50 | <0.001* |
| CD4 T lymphocytes (cells/μL) | 32 (17.98) | 317.50 (250.00–401.50) | 40 (14.04) | 293.00 (196.50–419.50) | 16090.00 | 0.097 |
| CD8 T lymphocytes (cells/μL) | 32 (17.98) | 274.50 (189.75–382.75) | 40 (14.04) | 258.00 (170.50–349.50) | 16524.00 | 0.208 |
APTB: active pulmonary tuberculosis; CT: computed tomography; ESR: erythrocyte sedimentation rate. aData are presented as the value of variable; *Significant influence.
Figure 1The comparison results of chest CT lesion degree in the patients with active pulmonary tuberculosis between smoking index (a), dust exposure time (b) and glycosylated hemoglobin (c). Score and single risk factor were used to evaluate the working characteristic curve of CT results of severe lesions (d). Age and score were supplemented by 100 and 10, respectively. Trend of incidence of severe lesions of chest CT and dust exposure rate with age (e). *p < 0.05; **p < 0.01.
Logistic regression analysis of chest CT lesion degree.
| Variable | Odds ratio | 95% | ||||
|---|---|---|---|---|---|---|
| Intercept | 0.706 | 0.513 | 1.894 | 0.169 | 2.026 | |
| Dust exposure | 1.413 | 0.271 | 27.218 | <0.001* | 4.108 | 2.416–6.986 |
| Classification of cases | 0.584 | 0.265 | 4.855 | 0.028* | 1.792 | 1.067–3.012 |
| Age | 0.017 | 0.006 | 7.673 | 0.006* | 1.018 | 1.005–1.030 |
| Duration of symptomsa | 0.021 | 0.011 | 3.764 | 0.052 | 1.022 | 1.000–1.044 |
| Albumin-globulin ratio | −1.720 | 0.388 | 19.652 | <0.001* | 0.179 | 0.084–0.383 |
CI: confidence interval; CT: computed tomography. a1/100 of the original data; *Significant influence.
Receiver operating characteristic analysis results of risk factors and score.
| Variable | AUC (95% CI) | Youden index | Cutoff value | Se | Sp | PPV (%) | NPV (%) | |
|---|---|---|---|---|---|---|---|---|
| Dust exposure | 0.633 (0.582–0.683) | <0.001 | 0.266 | NA | 0.876 | 0.390 | 47.27 | 83.46 |
| Classification of cases | 0.597 (0.545–0.649) | <0.001 | 0.194 | NA | 0.814 | 0.379 | 45.03 | 76.60 |
| Age | 0.627 (0.573–0.681) | <0.001 | 0.281 | 39.00 | 0.449 | 0.832 | 62.50 | 70.75 |
| Albumin-globulin ratio | 0.652 (0.601–0.703) | <0.001 | 0.258 | 0.918 | 0.697 | 0.561 | 49.80 | 74.77 |
| Score | 0.753 (0.708–0.798) | <0.001 | 0.371 | −0.085 | 0.539 | 0.832 | 66.67 | 74.92 |
AUC: area under the curve; CI: confidence interval; NA: not available; NPV: negative predictive value; PPV: positive predictive value; Se: sensitivity; Sp: specificity.
Figure 2Flowchart of the study population. APTB: Active pulmonary tuberculosis; CT: Computed tomography.
Figure 3Patch-like shadow (a), filamentous shadow (b), thick-walled cavity (c), mouth-eaten cavity (d), thin-walled cavity (e), thick wall + mixed mouth-eaten mixed cavity (f), speckled nodular shadow (g), cheese-like lesion (h).